Trial
NCT03938857
DOSE Trial of Opioid Sparing Effect
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Duke University
Collaborators
National Institutes of Health (NIH); Johns Hopkins University; Intermountain Health Care, Inc.; Vanderbilt University Medical Center
Condition
Dexmedetomidine
Intervention
Fentanyl
Why stopped
Enrollment challenging during the pandemic COVID 19
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-11-05